ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

In Brief: HHS Finds Fisher, Wickerham, Redmond Did Not Commit Scientific Misconduct

March 7, 1997

House Appropriations by Institute

July 8, 1994

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

ASCO Conquer Cancer Foundation Awards $6 Million To Researchers

April 22, 2011

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011